share_log

Scotiabank Initiates Coverage On Tempest Therapeutics With Sector Outperform Rating, Announces Price Target of $13

Scotiabank Initiates Coverage On Tempest Therapeutics With Sector Outperform Rating, Announces Price Target of $13

豐業銀行開始對Tempest Therapeutics進行報道,評級爲行業跑贏大盤,宣佈目標股價爲13美元
Moomoo 24/7 ·  03/13 17:24

Scotiabank analyst George Farmer initiates coverage on Tempest Therapeutics (NASDAQ:TPST) with a Sector Outperform rating and announces Price Target of $13.

豐業銀行分析師喬治·法默以行業跑贏大盤的評級啓動了對Tempest Therapeutics(納斯達克股票代碼:TPST)的報道,並宣佈目標股價爲13美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論